Market Cap | ₹128Cr |
ROE | 1.26% |
P/E Ratio(TTM) | 299.25 |
EPS(TTM) | 0.04 |
P/B Ratio | 2.13 |
Dividend Yield | 0.00% |
Industry P/E | 40.64 |
Book Value | 5.62 |
Debt to Equity | 0.19 |
Face Value | 2 |
Parent Organisation | Vaishali Pharma Limited |
Managing Director | Mr. Atul Vasani |
NSE Symbol | VAISHALI |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 102.84 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.38 | ||
Emcure Pharmaceuticals | NA (0.00%) | 33.75 | ||
Wockhardt | NA (0.00%) | -195.00 |